for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology

Size: px
Start display at page:

Download "for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology"

Transcription

1 Tadalafil 5 mg once daily for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology

2 Why this conference? Not promotional but educational The pharmacist regularly encounters patients who have been prescribed BPH/LUTS medications. The pharmacist regularly encounters patients who have been prescribed erectile dysfunction medications. The pharmacist regularly encounters patients who have been prescribed medications for the two conditions. The pharmacist have to know the rationale for the use of these medications prescribed very frequently and should be ready to answer patients questions. The pharmacist should be aware about any new indication such as Tadalafil 5mg daily for LUTS and ED.

3 Answers to common questions What is erectile dysfunction (ED)? What is «Lower urinary tract symptoms and Benign prostatic hyperplasia (LUTS/BPH)»? Is there a link between the two entities? What is the treatment of men with the two conditions simultaneously? Two medications or one for both?

4 Erectile Dysfunction: Introduction Erectile dysfunction (ED) is characterized by the consistent inability to attain or maintain an erection sufficient for satisfactory sexual intercourse 1 ED often 2-4 : Reduces motivation for sexual activity Creates a conscious focus on ED by the affected man Inhibits partner initiation of sexual activity 1. NIH Consensus Conference. JAMA 1993;270(1): Perelman M et al. J Sex Med 2005;2: Fisher W et al. J Sex Med 2005;2: Cameron A et al. J Sex Marital Ther 2005;31:

5

6 Erectile dysfunction: Causes Male sexual arousal is a complex process that involves the brain, hormones, emotions, nerves, muscles and blood vessels. ED can result from a problem with any of these. Likewise, stress and mental health problems can cause or worsen ED. Sometimes a combination of physical and psychological issues causes erectile dysfunction.

7 Erectile dysfunction: Consequences An unsatisfactory sex life Stress or anxiety Embarrassment or low self-esteem Marital or relationship problems Inability to get your partner pregnant

8 Erectile dysfunction: Treatment Check medications that could be causing or worsening ED (Ex. Beta Blockers.) Lifestyle change (Alcohol, Tobacco) Improve communication with the partner and consider couples or marriage counseling.

9 Erectile dysfunction: Treatment Phosphodiesterase inhibitors (PDE5I): The only oral drugs approved for use in ED Intracavernous injections of papaverine and Prostaglandin Intraurethral prostaglandin Penile prosthesis

10 Mechanism of erection Anatomy of the penis

11 Mechanism of erection Role of GMPc

12 Mechanism of erection Role of PDE5

13 Mechanism of erection Role of PDE5 Inhibitors

14 The central role of Nitric Oxide (NO) in erectile function Cavernous nerve Adrenergic fibres Norepinephrine p Non-adrenergic non-cholinergic fibres Cholinergic fibres Acetylcholine SMC CONTRACTION RELAXATION SMC (corpus cavernosum) NO SMC (local arteries) Endothelial cell RELAXATION BLOOD INFLOW Engorgement of sinusoidal spaces NO, nitric oxide SMC, smooth muscle cells INTRACAVERNOUS PRESSURE ERECTION VENOUS COMPRESSION ( BLOOD OUTFLOW) Dean RC, Lue TF. Urol Clin North Am. 2005;32(4):379-v.

15 How does Nitric Oxide (NO) affect smooth muscle cell relaxation? NO-cGMP signaling pathway causes a decrease in cytosolic Ca 2+ that directly leads to SMC Relaxation. Regulated by phospodiesterase-5 (PDE-5) breakdown of cgmp. cgmp, cyclic guanosine monophosphate GTP, guanosine triphosphate NO, nitric oxide PDE-5, phospodiesterase-5 SMC, smooth muscle cell Dean RC, Lue TF. Urol Clin North Am. 2005;32(4):379-v.

16 Mechanism of action of PDE5I

17 Tadalafil 20mg: What s beyond the 36 hours efficacy?

18 Tadalafil 20mg Men with ED were randomized to Tadalafil 20mg (n=1143) and placebo (n=538)

19 Do patients use the 36 hour window offered by tadalafil? Tadalafil 20mg

20 Tadalafil Men who reported successful intercourse with tadalafil were significantly more satisfied with the hardness of their erection than men who reported successful intercourse with Placebo

21 Why the Once-Daily Option Oral PDE5 inhibitors successfully treat ED 1 ; however, Ameliorating the full psychological impact of ED remains a challenge 2 One complication is the lack of a clear pattern of timing of sexual activity for many couples 2 Once-daily dosing would offer an alternative for couples who prefer spontaneous instead of scheduled sexual activities, or for those who anticipate frequent sexual activities 1. Eardley I et al. J Sex Med 2010;7: Fisher W et al. J Sex Med 2005;2:

22 tadalafil tadalafil

23

24

25 LUTS/BPH: Definition LUTS: obstructive and/or irritative symptoms May be secondary to prostatic obstruction or bladder problems Prostatic obstruction is due to Benign prostatic hyperplasia (BPH) LUTS/BPH is the right nomination

26 Link between ED and BPH-LUTS

27 Relationship between comorbidities and ED Cross-sectional study of men (n=2,476) aged 25 to 70 years in Spain Martin-Morales A, et al. J Urol. 2001;166(2):

28 LUTS severity correlates with the rate of ED Multinational Survey of the Aging Male (MSAM-7) in men (n=12,815) aged 50 to 80 years (US & EU) LUTS Severity Frequency (%) Age Cohort Association between increased severity of LUTS, rate of ED and age Base: Total sample years years years Net reduction of stiffness No, I cannot get an erection Rosen R, et al. Eur Urol. 2003;44(6):

29 The role of Nitric Oxide (NO) in the lower urinary tract Prostate, urethra and bladder neck: Densely supplied by nitric i oxide (NO)-synthase-containing i nerves 1 In the bladder and urethra: NO relaxes smooth muscle of the bladder neck and urethra during voiding 2,3 May also potentiate detrusor contraction during micturition 3 May also control afferent activity in the outlet region 2 In the prostate: NO regulates prostate smooth muscle tone 4 Also regulates local l blood flow 4 1. Hedland P. World J Urol. 2005;23(6): Andersson KE, Persson K. Scand J Urol Nephrol Suppl. 1995;175: Kajioka S, et al. Cell Calcium. 2008;44(2): Kedia GT, et al. World J Urol. 2008;26:603-9.

30 Strong epidemiological evidence supports a link between BPH-LUTS and ED A number of pathophysiological mechanisms are common to both conditions The nitric oxide/cyclic guanosine monophosphate h (NO/cGMP) signalling pathway has been widely implicated

31 The NO-cGMP pathway, with its action on smooth muscle tone, plays a central role in ED and is also involved in various aspects of LUT function this pathway is regulated by phosphodiesterase enzymes (PDE), providing a target for treatment with PDE-5 inhibitors Gacci M, et al. Eur Urol. 2011;60(4):

32 New approach to BPH-LUTS/ED In patients presenting with BPH-LUTS In patients presenting with ED Proactively inquire about co-morbid ED Proactively inquire about co-morbid LUTS The presence of co morbid BPH LUTS and ED has important implications on how each are managed Enables a comprehensive and integrated management plan to be developed May be jointly addressed d with combination drug therapy or single specific therapy Chitale S, et al. JSex Med. 2007;4:

33 20. Egerdie RB, et al. J Sex Med 2012; 9(1):

34 20. Egerdie RB, et al. J Sex Med 2012; 9(1):

35 European association of Urology Guidelines 2014 PDE5I in LUTS/BPH PDE5I reduce moderate-to-severe (storage and voiding) LUTS in men with or without erectile dysfunction ((Grade A recommandation) Only tadalafil (5 mg once daily) hasbeenlicensedfor y g y the treatment of male LUTS.

36 Tadalafil: Safety profile

37

38

39 ELaC1

40 Slide 39 ELaC1 remove reference 2 and 3 remove AEs after myalgia Eli Lilly and Company, 18/06/2012

41 Take home message With concomitant BPH-LUTS and ED, consider the effects of treatments on each of these conditions. Recent experimental and clinical data point to a role for PDE5I inhibitors inbph-lus. PDE5 inhibitor monotherapy may improve LUTS while also treating concomitant ED. PDE5 i hibit th i ED hil PDE5 inhibitor monotherapy may improve ED while also treating concomitant LUTS.

42 Take home message What should I advise my patients while dispensing a prescription of Tadalafil 5mg? Take tadalafil 5mg orally, once a day, at approximately the same time each day with or without food. A response to ED can be observed within 5 days of once a day dosing as this is when steady-state plasma concentrations are attained. Tadalafil has been shown to improve urinary symptoms as early as 1-2 weeks after commencing treatment. Seftel A. et al. zed, J Urol Jan; 185(1):243-8

43 10. Carson CC, et al. BJU Int. 2004;93: Cialis spc

44 FAQs What are the most common side effects of tadalafil? A. Headache, dyspepsia, ypp back pain B. Headache, flushing, back pain C. Headache, dyspepsia, flushing D. Nausea, dyspepsia, back pain

45 FAQs What should I advise my patients t while dispensing i a prescription of tadalafil 20mg? A. Take tadalafil 20mg orally at any time with or without food B. You should have coverage from 30minutes post dose up to 36 hours. C. Remember that Sexual stimulation is required for you to obtain an erection. D. All of the above

46 FAQs What should I advise my patients while dispensing a prescription of Tadalafil 5mg? A. Take tadalafil 5mg orally, once a day, at approximately the same time each day with or without food. B. A response to ED can be observed within 5 days of once a day dosing as this is when steady-state plasma concentrations are attained. C. Tadalafil has been shown to improve urinary symptoms as early as 1-2 weeks after commencing treatment. D. All of the above

47 Thank You

MMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS

MMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS Dr Tan & Partners MMM Vol. 1 No. 1 Morbidity & Mortality Meeting 14 th November 2014 Introduction Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS Tadalafil 5mg daily is a well established

More information

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT Basrah Journal Of Surgery EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT MB, ChB, FIBMS, Assistant Professor

More information

Erectile Dysfunction Medical Treatment

Erectile Dysfunction Medical Treatment 1 Erectile Dysfunction Medical Treatment Alireza Ghoreifi Assistant of Urology Mashhad University of Medical Sciences March 2012 2 Treatment of ED Unknown cases of ED First-line therapy Second-line therapy

More information

Managing Erectile Dysfunction

Managing Erectile Dysfunction Managing Erectile Dysfunction Lewis E. Harpster MD, FACS Urology of Central PA 4/23/16 1 Objectives 1. Review physiologic mechanism of erection 2. Discuss medical management of ED 3. Discuss surgical management

More information

MALE SEXUAL DYSFUNCTION. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara

MALE SEXUAL DYSFUNCTION. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara MALE SEXUAL DYSFUNCTION Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara DEFINITION The inability to achieve a satisfactory sexual relationship May involve : - inadequacy

More information

Erectile Dysfunction; It s Not Just About Sex

Erectile Dysfunction; It s Not Just About Sex Erectile Dysfunction; It s Not Just About Sex Disclosures Conflict of interest: I am not paid by Boston Scientific but once in a while they buy me a tasty meal. I do routinely use their products without

More information

IC351 (tadalafil, Cialis): update on clinical experience

IC351 (tadalafil, Cialis): update on clinical experience (2002) 14, Suppl 1, S57 S64 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir IC351 (tadalafil, Cialis): update on clinical experience 1 * 1 Urological practice,

More information

Evidence Review for Surrey Prescribing Clinical Network. Treatment: Oral and non-oral combination therapy for erectile dysfunction

Evidence Review for Surrey Prescribing Clinical Network. Treatment: Oral and non-oral combination therapy for erectile dysfunction Evidence Review for Surrey Prescribing Clinical Network Treatment: Oral and non-oral combination therapy for erectile dysfunction Prepared by: Linda Honey Topic Submitted by: Prescribing Clinical Network

More information

Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients

Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/10 Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients N. Narayanamoorthy,

More information

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014 Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011

More information

Erectile Dysfunction: A Primer for Primary Care Providers

Erectile Dysfunction: A Primer for Primary Care Providers Erectile Dysfunction: A Primer for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the definition, incidence and prevalence of Erectile Dysfunction in the U.S. 2. Understand

More information

SEXUAL HEALTH. Erectile Dysfunction

SEXUAL HEALTH. Erectile Dysfunction SEXUAL HEALTH Erectile Dysfunction Don t Let Erectile Dysfunction Keep You from a Satisfying Sex Life. What Is Erectile Dysfunction or ED? Who Gets ED? Men who have ED have a problem getting or keeping

More information

ERECTILE DYSFUNCTION. & Current Therapies. GP Conference, Rotorua 7-10 June 2012

ERECTILE DYSFUNCTION. & Current Therapies. GP Conference, Rotorua 7-10 June 2012 ERECTILE DYSFUNCTION & Current Therapies GP Conference, Rotorua 7-10 June 2012 Jan Burns & Annie Woodsford Jan: EN, RCpN, BHSc, RPN (USA),MHSc, Member of the Sexual Medicine Society Urology Nurse Specialist

More information

About Erectile Dysfunction. Causes, self-test and treatment

About Erectile Dysfunction. Causes, self-test and treatment About Erectile Dysfunction Causes, self-test and treatment 2015 One Way S.r.l. All rights reserved. Gift copy for physicians. Illustrated by Davide Ceccon With an unrestricted grant from Recordati About

More information

Diagnosis and management of sexual dysfunction. Dr Chris Simpson Consultant Psychiatrist

Diagnosis and management of sexual dysfunction. Dr Chris Simpson Consultant Psychiatrist Diagnosis and management of sexual dysfunction Dr Chris Simpson Consultant Psychiatrist What are we talking about? Male Erectile dysfunction Premature ejaculation Delayed ejaculation Sexual aversion Paraphilia

More information

REVIEW Validated questionnaires for assessing sexual dysfunction and BPH/LUTS: solidifying the common pathophysiologic link

REVIEW Validated questionnaires for assessing sexual dysfunction and BPH/LUTS: solidifying the common pathophysiologic link (2008) 20, S27 S32 & 2008 Nature Publishing Group All rights reserved 0955-9930/08 $30.00 www.nature.com/ijir REVIEW Validated questionnaires for assessing sexual dysfunction and BPH/LUTS: solidifying

More information

Canadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction

Canadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction Canadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction Last reviewed July 2014 Objectives 1. Define erectile dysfunction 2. List and classify the risk factors for erectile dysfunction

More information

Phosphodiesterase Type 5 Inhibitors Quantity Limit Program Summary

Phosphodiesterase Type 5 Inhibitors Quantity Limit Program Summary Phosphodiesterase Type 5 Inhibitors Quantity Limit Program Summary FDA APPROVED INDICATIONS AND DOSAGE 1-4,23 Agent FDA Approved Dosage and Administration Indication Cialis (tadalafil) (ED) ED; As needed:

More information

, David Stultz, MD. Erectile Dysfunction. David Stultz, MD September 10, 2001

, David Stultz, MD. Erectile Dysfunction. David Stultz, MD September 10, 2001 Erectile Dysfunction David Stultz, MD September 10, 2001 Case Presentation A 66 year old male presents to your office requesting Viagra. He states that for the past year he has had difficulty forming

More information

TADALAFIL THERAPY IN PATIENTS WITH CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME: RANDOMIZED, CONTROLLED TRIAL

TADALAFIL THERAPY IN PATIENTS WITH CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME: RANDOMIZED, CONTROLLED TRIAL AL-AZHAR ASSIUT MEDCAIL JOURNAL TADALAFIL THERAPY IN PATIENTS WITH CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME: RANDOMIZED, CONTROLLED TRIAL Department of Urology, Al-Azhar University, Cairo, Egypt.

More information

Managing the Patient with Erectile Dysfunction: What Would You Do?

Managing the Patient with Erectile Dysfunction: What Would You Do? Managing the Patient with Erectile Dysfunction: What Would You Do? Florida A & M University College of Pharmacy and Pharmaceutical Sciences 42 nd Annual Clinical Symposium Wayne A. Sampson, M.D. Cross

More information

Dipartimento Ostetricia, Ginecologia, Urologia - Clinica Urologica Università di Napoli Federico II, Italy; 2

Dipartimento Ostetricia, Ginecologia, Urologia - Clinica Urologica Università di Napoli Federico II, Italy; 2 ORIGINAL PAPER DOI: 10.4081/aiua.2016.2.128 A survey on the experience of 136 Italian urologists in the treatment of erectile dysfunction with PDE5 inhibitors and recommendations for the use of Avanafil

More information

ORIGINAL ARTICLE. Keywords: doxazosin GITS; erectile dysfunction; IPSS; lower urinary tract symptoms; quality of life; sildenafil

ORIGINAL ARTICLE. Keywords: doxazosin GITS; erectile dysfunction; IPSS; lower urinary tract symptoms; quality of life; sildenafil (2011) 13, 630 635 ß 2011 AJA, SIMM & SJTU. All rights reserved 1008-682X/11 $32.00 www.nature.com/aja ORIGINAL ARTICLE An open, comparative, multicentre clinical study of combined oral therapy with sildenafil

More information

/02/ /0 Vol. 168, , October 2002 THE JOURNAL OF UROLOGY

/02/ /0 Vol. 168, , October 2002 THE JOURNAL OF UROLOGY 0022-5347/02/1684-1332/0 Vol. 168, 1332 1336, October 2002 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2002 by AMERICAN UROLOGICAL ASSOCIATION, INC. DOI: 10.1097/01.ju.0000028041.27703.da Original

More information

H6D-MC-LVHR Clinical Study Report Synopsis Page LVHR Synopsis (LY450190)

H6D-MC-LVHR Clinical Study Report Synopsis Page LVHR Synopsis (LY450190) H6D-MC-LVHR Clinical Study Report Synopsis Page 1 2. LVHR Synopsis H6D-MC-LVHR Clinical Study Report Synopsis Page 2 Clinical Study Report Synopsis: Study H6D-MC-LVHR Title of Study: A Randomized, Double-Blind,

More information

JMSCR Vol 05 Issue 07 Page July 2017

JMSCR Vol 05 Issue 07 Page July 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i7.47 Original Research Article Tadalafil therapy

More information

Alpha antagonists from initial concept to routine clinical practice

Alpha antagonists from initial concept to routine clinical practice european urology 50 (2006) 635 642 available at www.sciencedirect.com journal homepage: www.europeanurology.com Editorial 50th Anniversary Alpha antagonists from initial concept to routine clinical practice

More information

Patient Information ERECTILE DYSFUNCTION. Department of Urology

Patient Information ERECTILE DYSFUNCTION. Department of Urology ERECTILE DYSFUNCTION What is erectile dysfunction? Erectile dysfunction (impotence) is the inability to get or keep an erection sufficient for sexual intercourse. One in ten men (10%) suffer from impotence

More information

Sexual dysfunction in male LUTS. M. Gacci Department of Urology, University of Florence

Sexual dysfunction in male LUTS. M. Gacci Department of Urology, University of Florence Sexual dysfunction in male LUTS M. Gacci Department of Urology, University of Florence Roma, 25-26 June, 2015 Cross-sectional population-based study of 4800 men (40 79 yr of age) UK, Netherlands, France,

More information

The effect of sildenafil on electrostimulation-induced erection in the rat model

The effect of sildenafil on electrostimulation-induced erection in the rat model (2002) 14, 251 255 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir The effect of sildenafil on electrostimulation-induced erection in the rat model N Ueno 1,

More information

김준철 가톨릭대학교의과대학비뇨기과학교실

김준철 가톨릭대학교의과대학비뇨기과학교실 비뇨기계자율신경병증의치료 김준철 가톨릭대학교의과대학비뇨기과학교실 Introduction Urologic complications have increasingly become a concern in those affected by DM Genitourinary problems are included among these complications, related

More information

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function www.kjurology.org DOI:10.4111/kju.2011.52.1.49 Sexual Dysfunction Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile

More information

MANAGEMENT UPDATE , LLC MedReviews

MANAGEMENT UPDATE , LLC MedReviews MANAGEMENT UPDATE 2013 MedReviews, LLC rostate cancer is the most common cancer in men over the age of 50 years. 1 When patients undergo a radical prostatectomy (RP), there is a risk of postoperative erectile

More information

Erectile dysfunction: unmet needs

Erectile dysfunction: unmet needs Erectile dysfunction: unmet needs Dimitris Hatzichristou Professor of Urology / Andrology Director, Center for Sexual and Reproductive Health Aristotle University of Thessaloniki, Greece The numbers MMAS

More information

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablative therapies, transurethral needle ablation, Adverse events, sexual side effects of BPH Aging, and incidence of BPH associated with

More information

ERECTILE DYSFUNCTION TREATMENTS

ERECTILE DYSFUNCTION TREATMENTS ERECTILE DYSFUNCTION TREATMENTS Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage

More information

Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction

Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction (2000) 12, Suppl 1, S75±S80 ß 2000 Macmillan Publishers Ltd All rights reserved 0955-9930/00 $15.00 www.nature.com/ijir Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of

More information

Schemi terapeutici complessi per la gestione della disfunzione erettile post trattamento del carcinoma prostatico: non solo PDE5i

Schemi terapeutici complessi per la gestione della disfunzione erettile post trattamento del carcinoma prostatico: non solo PDE5i Schemi terapeutici complessi per la gestione della disfunzione erettile post trattamento del carcinoma prostatico: non solo PDE5i M. Lazzeri MD-PhD Department of Urology Ist. Clinico Humanitas IRCCS Schema

More information

GUIDELINES ON ERECTILE DYSFUNCTION

GUIDELINES ON ERECTILE DYSFUNCTION 16 GUIDELINES ON ERECTILE DYSFUNCTION E. Wespes (chairman), E. Amar, D. Hatzichristou, Dr. F. Montorsi, J. Pryor, Y. Vardi Eur Urol 2002;41:1-5 1. Background, definition and classification Male erectile

More information

Jan Farrell Nurse Consultant Urological Services Department of Urology Rotherham General Hospital NHS FT

Jan Farrell Nurse Consultant Urological Services Department of Urology Rotherham General Hospital NHS FT Jan Farrell Nurse Consultant Urological Services Department of Urology Rotherham General Hospital NHS FT Aims of session To promote discussion / interaction Opportunity to discuss with peers Promote learning

More information

I N T I M A C Y A N D S E X U A L I T Y I N L A T E R L I F E

I N T I M A C Y A N D S E X U A L I T Y I N L A T E R L I F E I N T I M A C Y A N D S E X U A L I T Y I N L A T E R L I F E 2 0 1 6 DESPITE THE COMMON COMPLAINT, EACH PATIENT COMES AS AN INDIVIDUAL, WITH UNIQUE EXPECTATIONS My special interest Counseling patients

More information

National Institute for Health and Care Excellence. Lower Urinary Tract Symptoms Update Addendum Consultation Table 3 rd February 5 pm 3 rd March 2015

National Institute for Health and Care Excellence. Lower Urinary Tract Symptoms Update Addendum Consultation Table 3 rd February 5 pm 3 rd March 2015 British Association of Urological Surgeons British Association of Urological Surgeons National Institute for Health and Care Excellence Lower Urinary Tract Symptoms Update Addendum Consultation Table 3

More information

Effects of Isosorbide Dinitrate on the Urinary Flow Rate in Patients With Benign Prostatic Hyperplasia

Effects of Isosorbide Dinitrate on the Urinary Flow Rate in Patients With Benign Prostatic Hyperplasia Miscellaneous Effects of Isosorbide Dinitrate on the Urinary Flow Rate in Patients With Benign Prostatic Hyperplasia Ali Roshani, 1 Iraj Khosropanah, 1 Mohammad Salehi, 1 Alireza Noshad Kamran 2 Keywords:

More information

Quality of life issues after treatment for prostate cancer

Quality of life issues after treatment for prostate cancer Quality of life issues after treatment for prostate cancer Christopher Saigal MD, MPH Associate Professor, UCLA Department of Urology Definition of Health not merely the absence of disease or infirmity,

More information

Erectile dysfunction Simply explained

Erectile dysfunction Simply explained Ratgeber Erektionsstörungen Englisch... Erectile dysfunction Simply explained The Guide Contents Foreword 04 Erectile dysfunction Simply understood 05 Causes of erectile dysfunction 07 Treatment options

More information

13-Oct-15 ERECTILE DYSFUNCTION. Urology Subdepartement dr. Mintohardjo Naval Hospital dr. Isdiyanto Septiadi, Sp.U

13-Oct-15 ERECTILE DYSFUNCTION. Urology Subdepartement dr. Mintohardjo Naval Hospital dr. Isdiyanto Septiadi, Sp.U ERECTILE DYSFUNCTION Urology Subdepartement dr. Mintohardjo Naval Hospital dr. Isdiyanto Septiadi, Sp.U 1 2 3 So what is impotence or erectile dysfunction..? The persistent inability to achieve or maintain

More information

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size

More information

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP Introduction to Enlarged Prostate E. David Crawford, MD Professor of Surgery (Urology) and Radiation Oncology Head, Urologic Oncology E. David Crawford Endowed Chair in Urologic Oncology University of

More information

Management of Post-Prostatectomy Urinary Incontinence and Sexual Dysfunction

Management of Post-Prostatectomy Urinary Incontinence and Sexual Dysfunction Management of Post-Prostatectomy Urinary Incontinence and Sexual Dysfunction Robert C. Eyre, MD, FACS Associate Clinical Professor of Surgery (Urology) Harvard Medical School Post-prostatectomy Incontinence

More information

Erectile dysfunction. By Anas Hindawi Supervised by Dr Khalid AL Sayyid

Erectile dysfunction. By Anas Hindawi Supervised by Dr Khalid AL Sayyid Erectile dysfunction By Anas Hindawi Supervised by Dr Khalid AL Sayyid ED is the persistent/recurrent inability to attain and/or maintain a penile erection rigid enough for satisfactory sexual intercourse

More information

ED treatments: PDE5 inhibitors, injections and vacuum devices

ED treatments: PDE5 inhibitors, injections and vacuum devices ED treatments: PDE5 inhibitors, injections and vacuum devices Martin Steggall Clinical Nurse Specialist (Erectile Dysfunction and Premature Ejaculation) Barts Health NHS Trust; Associate Dean, Director

More information

Moving Beyond Cancer To A New Normal in Intimacy For Men & Their Partners. Presented by Mary Ellen West, RN, MN, CNM AASECT Certified Sex Counselor

Moving Beyond Cancer To A New Normal in Intimacy For Men & Their Partners. Presented by Mary Ellen West, RN, MN, CNM AASECT Certified Sex Counselor Moving Beyond Cancer To A New Normal in Intimacy For Men & Their Partners Presented by Mary Ellen West, RN, MN, CNM AASECT Certified Sex Counselor WHO Definition of Sexuality Central aspect of being human

More information

Onset and duration of action of sildena l citrate for the treatment of erectile dysfunction

Onset and duration of action of sildena l citrate for the treatment of erectile dysfunction Onset and duration of action of sildena l citrate for the treatment of erectile dysfunction Ian Eardley, 1 Peter Ellis, 2 Mitradev Boolell 2 & Maria Wulff 2 1 Department of Urology, St James University

More information

Defined as the consistent inability to attain and maintain an erection adequate for sexual intercourse Usually qualified by being present for several

Defined as the consistent inability to attain and maintain an erection adequate for sexual intercourse Usually qualified by being present for several Defined as the consistent inability to attain and maintain an erection adequate for sexual intercourse Usually qualified by being present for several months and occurring at least half the time. Vinik

More information

Cialis. Cialis (tadalafil) Description

Cialis. Cialis (tadalafil) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.06.02 Subject: Cialis Page: 1 of 5 Last Review Date: September 18, 2015 Cialis Description Cialis (tadalafil)

More information

MEN NEED GOOD TOOLS. Men Need Good Tools. power, performance, price.

MEN NEED GOOD TOOLS. Men Need Good Tools. power, performance, price. MEN NEED GOOD TOOLS Men Need Good Tools power, performance, price www.vedafil.co.nz Congratulations on taking the first step... Erection problems are common Erectile dysfunction (ED) is a common condition

More information

Erectile Dysfunction (Impotence)

Erectile Dysfunction (Impotence) Page 1 of 6 Erectile Dysfunction (Impotence) Erectile dysfunction (ED) means that you cannot get a proper erection. There are various causes. However, most cases are due to narrowing of the arteries that

More information

Erectile Dysfunction Prior Authorization with Quantity Limit Criteria Program Summary

Erectile Dysfunction Prior Authorization with Quantity Limit Criteria Program Summary Prior Authorization with Quantity Limit Criteria Program Summary Objective The intent of the prior authorization (PA) program for (ED) is to ensure appropriate selection of patients for treatment according

More information

A review of phosphodiesterase type 5 inhibitors

A review of phosphodiesterase type 5 inhibitors A review of phosphodiesterase type 5 inhibitors Abstract Schellack N, BCur, BPharm, PhD(Pharmacy), Senior Lecturer Agoro A, BPharm, Academic Intern Department of Pharmacy, Faculty of Health Sciences, University

More information

Jan Farrell. Nurse Consultant Urology Department of Urology Rotherham General Hospital NHS FT

Jan Farrell. Nurse Consultant Urology Department of Urology Rotherham General Hospital NHS FT Jan Farrell Nurse Consultant Urology Department of Urology Rotherham General Hospital NHS FT Aims of session To promote discussion / interaction Opportunity to discuss with peers Promote learning / share

More information

Erectile Dysfunction Case Study 2. Medical Student Case-Based Learning

Erectile Dysfunction Case Study 2. Medical Student Case-Based Learning Erectile Dysfunction Case Study 2 Medical Student Case-Based Learning The Case of Mr. Power s Limp Mojo Mr. Powers develops erectile dysfunction after his radical prostatectomy for prostate cancer. You

More information

THE FACTS ABOUT MEN S SEXUAL HEALTH

THE FACTS ABOUT MEN S SEXUAL HEALTH Come in and experience the Chesapeake Urology difference. Call 877-422-8237 to make an appointment with a urologist today or visit www.chesapeakeurology.com to learn more about our specialized care for

More information

ERECTILE DYSFUNCTION DIAGNOSIS

ERECTILE DYSFUNCTION DIAGNOSIS ERECTILE DYSFUNCTION DIAGNOSIS Head of Andrology and Sexual Medicine Dep.of Urology and Nefrology Hospital Virgen del Rocío ANDROMEDI. Sexual Medicine SEVILLA. SPAIN General Secretary ESSM Natalio Cruz

More information

Cialis. Cialis (tadalafil) Description

Cialis. Cialis (tadalafil) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.22 Subject: Cialis Page: 1 of 5 Last Review Date: September 15, 2017 Cialis Description Cialis (tadalafil)

More information

Erectile Dysfunction and the Prostate Cancer Patient

Erectile Dysfunction and the Prostate Cancer Patient BAUN & Prostate cancer UK Erectile Dysfunction Study Day Erectile Dysfunction and the Prostate Cancer Patient Lorraine Montgomery Specialist Nurse Practitioner Urology Queen Elizabeth Hospital Gateshead

More information

Phosphodiesterase Type 5 Inhibitors for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Phosphodiesterase Type 5 Inhibitors for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Urol Sci 2010;21(1):2 7 CME Credits MINI REVIEW Phosphodiesterase Type 5 Inhibitors for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Shih-Tsung Huang* Division of Andrology

More information

Clinic for urology, pediatric urology and andrology. Penile diseases. Dr. Arne Hauptmann

Clinic for urology, pediatric urology and andrology. Penile diseases. Dr. Arne Hauptmann Clinic for urology, pediatric urology and andrology JUSTUS- LIEBIG UNVERISTY GIESSEN Penile diseases Dr. Arne Hauptmann Clinic for urology, pediatric urology and andrology University Giessen und Marburg

More information

Testosterone and PDE5 inhibitors in the aging male

Testosterone and PDE5 inhibitors in the aging male Testosterone and PDE5 inhibitors in the aging male Francesco Romanelli Department of Experimental Medicine Medical Pathophysiology, Food Science and Endocrinology Section Sapienza University of Rome 3005

More information

Will Medical Management of Benign Prostatic Hyperplasia Result in Better or Worse Sexual Function in Men?

Will Medical Management of Benign Prostatic Hyperplasia Result in Better or Worse Sexual Function in Men? Urol Sci 2011;22(1):14 18 MINI REVIEW Will Medical Management of Benign Prostatic Hyperplasia Result in Better or Worse Sexual Function in Men? Thomas I.S. Hwang 1,2,3 * 1 Shin Kong WHS Hospital, Taipei,

More information

Questions & Answers about Sexuality and Intimacy after Bladder Cancer. Part III: Causes and Treatments for Sexual Dysfunction

Questions & Answers about Sexuality and Intimacy after Bladder Cancer. Part III: Causes and Treatments for Sexual Dysfunction Questions & Answers about Sexuality and Intimacy after Bladder Cancer A Valentine's chat with Dr. Trinity Bivalacqua Monday, February 13, 2017 Part III: Causes and Treatments for Sexual Dysfunction Presented

More information

GUIDELINES ON ERECTILE DYSFUNCTION

GUIDELINES ON ERECTILE DYSFUNCTION GUIDELINES ON ERECTILE DYSFUNCTION (Text updated March 2005) E. Wespes (chairman), E. Amar, D. Hatzichristou, K. Hatzimouratidis, F. Montorsi, J. Pryor, Y. Vardi 88 Erectile Dysfunction Eur Urol 2001;40:97-101

More information

Association of BPH with OAB: The Plumbing or the Pump?

Association of BPH with OAB: The Plumbing or the Pump? Association of BPH with OAB: The Plumbing or the Pump? Ryan P. Terlecki, MD FACS Associate Professor of Urology Director, Men s Health Clinic Director, GURS Fellowship in Reconstructive Urology, Prosthetic

More information

european urology 53 (2008)

european urology 53 (2008) european urology 53 (2008) 1236 1244 available at www.sciencedirect.com journal homepage: www.europeanurology.com Benign Prostatic Enlargement A Randomised, Placebo-Controlled Study to Assess the Efficacy

More information

THE RELEVANCE OF TESTOSTERONE THERAPY IN MANAGING PATIENTS WITH ERECTILE DYSFUNCTION

THE RELEVANCE OF TESTOSTERONE THERAPY IN MANAGING PATIENTS WITH ERECTILE DYSFUNCTION THE RELEVANCE OF TESTOSTERONE THERAPY IN MANAGING PATIENTS WITH ERECTILE DYSFUNCTION Aksam A. Yassin MD PhD EdD FEBU Professor of Urology & Human Sexuality Institute of Urology & Andrology, Segeberger

More information

Sexual Function for Men with Spinal Cord Injury

Sexual Function for Men with Spinal Cord Injury Sexual Function for Men with Spinal Cord Injury A spinal cord injury (SCI) affects a man's sexuality both physically and psychologically. The type and level of injury both can play a role on the impact

More information

Single Technology Appraisal (STA) Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia

Single Technology Appraisal (STA) Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia Comment 1: the draft remit Appendix D - NICE s response to consultee and commentator comments on the draft scope and provisional matrix National Institute for Health and Clinical Excellence Single Technology

More information

Opinion: Yes. PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation?

Opinion: Yes. PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation? Difference of opinion Vol. 43 (3): 385-389, May - June, 2017 doi: 10.1590/S1677-5538.IBJU.2017.03.03 PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation? Opinion:

More information

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE. Bulletin 169: Daily Tadalafil (Cialis ) for penile rehabilitation following radical prostactectomy

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE. Bulletin 169: Daily Tadalafil (Cialis ) for penile rehabilitation following radical prostactectomy BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE September 2012 Review date: September 2014 Bulletin 169: Daily Tadalafil (Cialis ) for penile rehabilitation following radical prostactectomy JPC Recommendation:

More information

Erectile Dysfunction (ED) Shawn McGee M.D. CentraCare Adult and Pediatric Urology January 30 th, 2016

Erectile Dysfunction (ED) Shawn McGee M.D. CentraCare Adult and Pediatric Urology January 30 th, 2016 Erectile Dysfunction (ED) Shawn McGee M.D. CentraCare Adult and Pediatric Urology January 30 th, 2016 Erectile dysfunction: The inability to attain or maintain penile erection sufficient for satisfactory

More information

The Impact of Mental Illness on Sexual Dysfunction

The Impact of Mental Illness on Sexual Dysfunction Balon R (ed): Sexual Dysfunction. The Brain-Body Connection. Adv Psychosom Med. Basel, Karger, 2008, vol 29, pp 89 106 The Impact of Mental Illness on Sexual Dysfunction Zvi Zemishlany Abraham Weizman

More information

Tobacco and Sex - What?

Tobacco and Sex - What? Tobacco and Sex - What? Arlene Evans-De Beverly, PA-C Copyright 2011 Tobacco use is well-known to cause health problems. We all know about the increase risk of lung cancer, heart disease and strokes. Some

More information

What is your specialty?

What is your specialty? What is your specialty? A. General practice B. Urology C. Andrology D. Other Do you keep up with news about ED and BPH? A. No B. Yes, weekly or more frequently C. Yes, monthly D. Yes, annually or less

More information

Medical Management of Erectile Dysfunction. Maarten Albersen MD PhD University Hospitals Leuven,

Medical Management of Erectile Dysfunction. Maarten Albersen MD PhD University Hospitals Leuven, Medical Management of Erectile Dysfunction Maarten Albersen MD PhD University Hospitals Leuven, Belgium @maartenalbersen COI Consultancy/speaker for: Ferring, Sanofi, BSCI, Coloplast, Pfizer, Lilly, Menarini,

More information

A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction

A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction 625408TAU0010.1177/1756287215625408Therapeutic Advances in UrologyMC Cho and J Paick research-article2016 Therapeutic Advances in Urology Review A review of the efficacy and safety of mirodenafil in the

More information

A prospective study of sexual dysfunction in patients with benign prostatic hyperplasia

A prospective study of sexual dysfunction in patients with benign prostatic hyperplasia International Surgery Journal Leelakrishna P et al. Int Surg J. 218 Mar;5(3):82-89 http://www.ijsurgery.com pissn 2349-335 eissn 2349-292 Original Research Article DOI: http://dx.doi.org/1.1823/2349-292.isj2185

More information

Tadalafil: a novel treatment for erectile dysfunction

Tadalafil: a novel treatment for erectile dysfunction European Heart Journal Supplements (22) 4 (Supplement H), H24 H31 Tadalafil: a novel treatment for erectile dysfunction F. Giuliano 1 and L. Varanese 2 1 Department of Urology, AP-HP, Centre Hospitalier

More information

Assessment of Erectile and Ejaculatory Function after Penile Prosthesis Implantation

Assessment of Erectile and Ejaculatory Function after Penile Prosthesis Implantation www.kjurology.org DOI:.4/kju.2.5.3.22 Sexual Dysfunction/Infertility Assessment of Erectile and Ejaculatory Function after Penile Prosthesis Implantation Jang Ho Bae, Phil Hyun Song, Hyun Tae Kim, Ki Hak

More information

GUIDELINES ON PRIAPISM

GUIDELINES ON PRIAPISM GUIDELINES ON PRIAPISM (Text update March 2015) A. Salonia, I. Eardley, F. Giuliano, I. Moncada, K. Hatzimouratidis Eur Urol 2014 Feb;65(2):480-9 Introduction Priapism is a pathological condition representing

More information

Sexual impotence. the forgotten complication

Sexual impotence. the forgotten complication Sexual impotence the forgotten complication CHECK YOURSELF YOUR SEXUAL PERFORMANCE 1. Have you had recently difficulties achieving a full erection? 2. Does it happens at least two out of four times trying

More information

INTRODUCTION MISCELLANEOUS

INTRODUCTION MISCELLANEOUS MISCELLANEOUS Comparing Monotherapy with Tadalafil or Tamsulosin and Their Combination Therapy in Men with Benign Prostatic Hyperplasia: A Randomized Clinical Trial Hossein Karami*, Amin Hassanzadeh-Hadad,

More information

BPH: a present and future perspective on health impact

BPH: a present and future perspective on health impact BPH: a present and future perspective on health impact Burden of disease in men with moderate LUTS Dalibor Pacík This presentation is financially supported by GlaxoSmithKline. CZ/DUTT/0019/12 Men with

More information

A Proposed Study of Hyperbaric Oxygen Therapy Following Radical Prostatectomy: Effects on Erectile Dysfunction

A Proposed Study of Hyperbaric Oxygen Therapy Following Radical Prostatectomy: Effects on Erectile Dysfunction A Proposed Study of Hyperbaric Oxygen Therapy Following Radical Prostatectomy: Effects on Erectile Dysfunction Anthony J. Bella MD, FRCSC Division of Urology, Department of Surgery and Department of Neuroscience

More information

Daily vs. on-demand PDE-5 inhibitors for management of erectile dysfunction following treatment for prostate cancer

Daily vs. on-demand PDE-5 inhibitors for management of erectile dysfunction following treatment for prostate cancer Daily vs. on-demand PDE-5 inhibitors for management of erectile dysfunction following treatment for prostate cancer Lead author: Nancy Kane Regional Drug & Therapeutics Centre (Newcastle) February 2018

More information

Male Pelvic Health following Pelvic Surgery

Male Pelvic Health following Pelvic Surgery Male Pelvic Health following Pelvic Surgery Radical Pelvic Surgery Associated Sexual Dysfunction Pathophysiology Post Radical Prostatectomy (RP) Sexual Dysfunctions Erectile dysfunction (ED) Anejaculation

More information

The Centre for Men s Health

The Centre for Men s Health 96 Harley Street (London) and Manchester All Enquiries - +44 (0)20 7486 2277 www.centreformenshealth.co.uk/ This leaflet provides information about: The Centre for Men s Health The conditions we treat:

More information

MODULE 4: ERECTILE DYSFUNCTION

MODULE 4: ERECTILE DYSFUNCTION MODULE 4: ERECTILE DYSFUNCTION KEYWORDS: Erectile dysfunction, phosphodiesterase inhibitors, sexual dysfunction LEARNING OBJECTIVES At the end of this clerkship, the medical student will be able to: 1.

More information

Erectile dysfunction (ED) is the inability to obtain or maintain an erection satisfactory

Erectile dysfunction (ED) is the inability to obtain or maintain an erection satisfactory Determining the Feasibility of Managing Erectile Dysfunction in Humans With Placental-Derived Stem Cells Jason A. Levy, OMS IV, MS; Melissa Marchand, PA-C; Leanne Iorio, OMS II; Walquiria Cassini; and

More information

aviptadil / phentolamine 25 micrograms / 2mg solution for injection (Invicorp ) SMC No 1284/17 Evolan Pharma AB

aviptadil / phentolamine 25 micrograms / 2mg solution for injection (Invicorp ) SMC No 1284/17 Evolan Pharma AB aviptadil / phentolamine 25 micrograms / 2mg solution for injection (Invicorp ) SMC No 1284/17 Evolan Pharma AB 10 November 2017 The Scottish Medicines Consortium (SMC) has completed its assessment of

More information

Benign Prostatic Hyperplasia. Management of Benign Prostatic Hyperplasia. Goals of Therapy

Benign Prostatic Hyperplasia. Management of Benign Prostatic Hyperplasia. Goals of Therapy Benign Prostatic Hyperplasia Management of Benign Prostatic Hyperplasia Goals of Therapy Improve or abolish lower urinary tract symptoms (LUTS) Prevent or delay clinical progression of benign prostatic

More information